Moreover, disulfiram proved to diminish the ALDH1+ population from non-small cell lung cancer cell lines (Liu et al., 2016) and CD34+CD38+ cells in AML cell lines and primary samples in vitro and in vivo (Xu et al., 2017). This evidence concerns the gene CD34 and acute myeloid leukemia.